
Biological sex has a small but ubiquitous influence on gene expression in almost every type of human tissue, according to a new study.

A new combination therapy targeting breast cancer tumors in the brain dramatically decreased tumor size and increased survival in mice, according to a new study.

Two Feinberg faculty members in the Department of Medical Education have been honored with awards for humanism in medicine and teaching from the Association of American Medical Colleges. (AAMC).

Sarki Abdulkadir, MD, PhD, has been named the winner of the 2020 Tripartite Legacy Faculty Prize in Translational Science and Education for his work investigating the molecular pathways that drive prostate cancer.

Genomic alterations in prostate cancer therapeutic targets were found to be similar between African American and European American men, suggesting that existing precision medicine approaches could equally benefit both groups if applied equitably, according to a recent study.

Deaths due to heart failure and hypertensive heart disease are increasing in the U.S. — particularly in Black women and men — despite medical and surgical advances in heart disease management, according to a new Northwestern Medicine study.

Diane B. Wayne, MD, has indicated that she would like to step down as vice-dean for medical education; Marianne Green, MD, will succeed her. Sandra Sanguino, MD, MPH, has been named senior associate dean for Medical Education, and Joshua Goldstein, MD, has been elevated to senior associate dean for graduate medical education.

Matthew Davis, MD, a pediatrician and internist with a focus on family health and community impact, has been named chair of the Department of Pediatrics at Feinberg and Ann & Robert H. Lurie Children’s Hospital of Chicago.

Four Northwestern Medicine hospitals have been recognized by U.S. News & World Report in its 2020-21 Best Hospitals rankings, with Northwestern Memorial Hospital named among the top 10 hospitals in the U.S.

A new immunotherapy developed by investigators at Northwestern University dramatically extends the survival time of mice with triple negative breast cancer, one of the most aggressive and difficult-to-treat forms of breast cancer.